Clinical trial
Safety Study of Bromfenac Ophthalmic Solution in Subjects With Diffuse Diabetic…
NCT00491166 · Ophthalmic Consultants of Boston, Other · Unknown status
Key facts
| NCT number | NCT00491166 |
|---|---|
| Title | Safety Study of Bromfenac Ophthalmic Solution in Subjects With Diffuse Diabetic Macular Edema (DME) Refractory to Laser |
| Official title | A Single-Center, Investigator-Sponsored Pilot Study to Assess Safety and Biologic Activity of Bromfenac Ophthalmic Solution, 0.09%, in Subjects With Diffuse DME Refractory to Laser |
| Lead sponsor | Ophthalmic Consultants of Boston, Other |
| Collaborators | Bausch & Lomb Incorporated Industry |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Diabetic Macular Edema |
| Intervention type | Drug |
| Interventions | Bromfenac ophthalmic solution |
| Enrollment | 10 |
| Start date | Jun 1, 2007 |
| First posted | Jun 25, 2007 |
| Last update posted | Jun 25, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: